These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38383428)

  • 1. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
    Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
    J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
    Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
    J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood-based protein biomarker panel for the detection of colorectal cancer.
    Fung KY; Tabor B; Buckley MJ; Priebe IK; Purins L; Pompeia C; Brierley GV; Lockett T; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Nice E; Adams TE; Burgess A; Cosgrove LJ
    PLoS One; 2015; 10(3):e0120425. PubMed ID: 25793510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.
    Ladd JJ; Busald T; Johnson MM; Zhang Q; Pitteri SJ; Wang H; Brenner DE; Lampe PD; Kucherlapati R; Feng Z; Prentice RL; Hanash SM
    Cancer Prev Res (Phila); 2012 Apr; 5(4):655-64. PubMed ID: 22277732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.
    Jiang X; Bai XY; Li B; Li Y; Xia K; Wang M; Li S; Wu H
    Dis Markers; 2019; 2019():5069614. PubMed ID: 31481982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer.
    Verathamjamras C; Chantaraamporn J; Sornprachum T; Mutapat P; Chokchaichamnankit D; Mingkwan K; Luevisadpibul V; Srisomsap C; Chutipongtanate S; Svasti J; Champattanachai V
    Clin Proteomics; 2023 Apr; 20(1):15. PubMed ID: 37024778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
    Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
    Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Biomarkers Panels for Screening of Colorectal Cancer and Adenoma on a Machine Learning-Assisted Detection Platform.
    Wang H; Zhou Z; Li H; Xiang W; Lan Y; Dou X; Zhang X
    Cancer Control; 2023; 30():10732748231222109. PubMed ID: 38146088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass Spectrometry Proteomics Characterization of Plasma Biomarkers for Colorectal Cancer Associated With Inflammation.
    Urbiola-Salvador V; Jabłońska A; Miroszewska D; Kamysz W; Duzowska K; Drężek-Chyła K; Baber R; Thieme R; Gockel I; Zdrenka M; Śrutek E; Szylberg Ł; Jankowski M; Bała D; Zegarski W; Nowikiewicz T; Makarewicz W; Adamczyk A; Ambicka A; Przewoźnik M; Harazin-Lechowska A; Ryś J; Macur K; Czaplewska P; Filipowicz N; Piotrowski A; Dumanski JP; Chen Z
    Biomark Insights; 2024; 19():11772719241257739. PubMed ID: 38911905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
    Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
    Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer.
    Okuda Y; Shimura T; Abe Y; Iwasaki H; Nishigaki R; Fukusada S; Sugimura N; Kitagawa M; Yamada T; Taguchi A; Kataoka H
    J Gastroenterol; 2024 Jul; 59(7):572-585. PubMed ID: 38836911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.